Sarah Able
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Physiology top 10%
Papers in
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
-
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Katherine A. Vallis (18 shared papers)Ole Tietz (3 shared papers)R. Chalk (2 shared papers)Fernando Cortezon‐Tamarit (1 shared paper)Bart Cornelissen (5 shared papers)Veerle Kersemans (5 shared papers)Carolyn Napier (3 shared papers)Sidath Katugampola (2 shared papers)
- Journals
- Journal of Nuclear Medicine (2 papers)Molecular Cancer Therapeutics (1 paper)Chemical Science (1 paper)Nanoscale (1 paper)Life Sciences (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Sarah Able
22 papers receiving 624 citations
Peers
Comparison fields: 5 of 82
- Biomaterials 113
- Physiology 38
- Radiology, Nuclear Medicine and Imaging 112
- Biomedical Engineering 180
- Molecular Biology 260
Countries citing papers authored by Sarah Able
This map shows the geographic impact of Sarah Able's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Able with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Able more than expected).
Fields of papers citing papers by Sarah Able
This network shows the impact of papers produced by Sarah Able. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Able. The network helps show where Sarah Able may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Able, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 117 | |
| 2 | 2012 | 78 | |
| 3 | 2018 | 68 | |
| 4 | 2012 | 64 | |
| 5 | 2010 | 43 | |
| 6 | 2021 | 34 | |
| 7 | 2018 | 28 | |
| 8 | 2017 | 22 | |
| 9 | 2013 | 21 | |
| 10 | 2021 | 20 | |
| 11 | 2021 | 20 | |
| 12 | 2016 | 17 | |
| 13 | 2021 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2009 | 14 | |
| 16 | 2019 | 13 | |
| 17 | 2014 | 13 | |
| 18 | 2017 | 11 | |
| 19 | 2009 | 10 | |
| 20 | 2017 | 3 |
About Sarah Able
Sarah Able is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Biomedical Engineering and Biomaterials, having authored 22 papers that have together received 627 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Radiation Therapy and Dosimetry (3 papers), Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Biomaterials (113 citations), Physiology (38 citations), Radiology, Nuclear Medicine and Imaging (112 citations), Biomedical Engineering (180 citations) and Molecular Biology (260 citations). Sarah Able has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Katherine A. Vallis, Ole Tietz, R. Chalk, Fernando Cortezon‐Tamarit, Bart Cornelissen, Veerle Kersemans, Carolyn Napier, Sidath Katugampola, William B. Johnson and Siân E. Harding. Their work appears in journals such as Journal of Nuclear Medicine, Molecular Cancer Therapeutics, Chemical Science, Nanoscale and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.